​

Replimune Group (REPL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Replimune Group Revenue Highlights

00

Replimune Group Revenue by Period

Replimune Group Revenue by Year

DateRevenueChange
2024-03-31-100.00%
2023-03-31-100.00%
2022-03-31-100.00%
2021-03-31-100.00%
2020-03-31-100.00%
2019-03-31-100.00%
2018-03-31-100.00%
2017-03-31--

Replimune Group generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Replimune Group Revenue by Quarter

DateRevenueChange
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30--100.00%
2024-03-31$4.04M100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Replimune Group generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Replimune Group Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
UTHRUnited Therapeutics$2.88B$748.90M
ASNDAscendis Pharma$266.72M$95.89M
GOSSGossamer Bio$114.70M$9.48M
KURAKura Oncology$53.88M-
NAMSNewAmsterdam Pharma$45.56M$2.13M
MRUSMerus$36.13M$11.77M
SNDXSyndax Pharmaceuticals$23.68M$12.50M
KRONKronos Bio$9.85M$2.37M
KROSKeros Therapeutics$3.55M$37.00K
PRTCPureTech Health$3.33M$178.57K
LYRALyra Therapeutics$1.53M$195.00K
CRNXCrinetics Pharmaceuticals$1.04M-
PTGXProtagonist Therapeutics-$4.67M
VTYXVentyx Biosciences--
NUVLNuvalent--
REPLReplimune Group--
AVTEAerovate Therapeutics--
NVCTNuvectis Pharma--
MLYSMineralys Therapeutics--

REPL Revenue FAQ

What is Replimune Group’s yearly revenue?

Replimune Group's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. REPL's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Replimune Group’s quarterly revenue?

Replimune Group's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). REPL's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Replimune Group’s revenue growth rate?

Replimune Group's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.